Finance

Lists
APLLTD:NSE
Alembic Pharmaceuticals Ltd
1 045,30 INR
+0,09%
(+0,95) 1D
19-ноя., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
1 044,35 INR
High
1 054,25 INR
Low
1 038,50 INR
Mkt. cap
205,97 млд
Avg. vol.
463,85 миң
Volume
333,41 миң
Dividend
1,15%
Quarterly dividend
3,00 INR
Ex-dividend date
2026-ж., 29-июл.
P/E ratio
24,36
52-wk high
1 075,00 INR
52-wk low
635,80 INR
EPS
42,92 INR
Shares outstanding
188,50 млн
No. of employees
17 миң
Open
1 044,35 INR
High
1 054,25 INR
Low
1 038,50 INR
Mkt. cap
205,97 млд
Avg. vol.
463,85 миң
Volume
333,41 миң
Dividend
1,15%
Quarterly dividend
3,00 INR
Ex-dividend date
2026-ж., 29-июл.
P/E ratio
24,36
52-wk high
1 075,00 INR
52-wk low
635,80 INR
EPS
42,92 INR
Shares outstanding
188,50 млн
No. of employees
17 миң
News stories
From web sources and news partners
About Alembic Pharmaceuticals Ltd
CEO-
Employees17,2 миң
Founded1907
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Website-
Last report
2026-ж., 4-ноя.
Fiscal period
Q2 2027
39,31 INR / 10,97 INR
+258,45%beat
Revenue / Est. (INR)
26,03 млд / 23,34 млд
+11,57%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
18,76 млд
18,48 млд
21,50 млд
26,03 млд
Cost of goods sold
5,29 млд
6,27 млд
6,20 млд
6,86 млд
Cost of revenue
5,29 млд
6,27 млд
6,20 млд
6,86 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,33 млд
4,39 млд
4,74 млд
5,04 млд
Operating expense
11,34 млд
10,85 млд
12,96 млд
14,55 млд
Total operating expenses
16,63 млд
17,11 млд
19,16 млд
21,41 млд
Operating income
2,13 млд
1,36 млд
2,34 млд
4,62 млд
Other non operating income
154,90 млн
-285,60 млн
149,30 млн
151,20 млн
EBT including unusual items
1,61 млд
1,19 млд
2,22 млд
4,38 млд
EBT excluding unusual items
2,04 млд
1,37 млд
2,22 млд
4,38 млд
Income tax expense
295,40 млн
-829,00 млн
495,00 млн
1,04 млд
Effective tax rate
18,29%
-69,88%
22,31%
23,76%
Other operating expenses
6,21 млд
5,56 млд
7,24 млд
8,51 млд
Net income
1,33 млд
2,03 млд
1,73 млд
3,35 млд
Net profit margin
7,09%
10,97%
8,05%
12,87%
Earnings per share
8,51
11,57
8,80
39,31
Interest and investment income
-
8,60 млн
-
-
Interest expense
-233,10 млн
-225,60 млн
-276,10 млн
-382,60 млн
Net interest expenses
-233,10 млн
-217,00 млн
-276,10 млн
-382,60 млн
Depreciation and amortization charges
801,20 млн
885,90 млн
977,10 млн
1,01 млд
EBITDA
2,78 млд
2,12 млд
3,09 млд
5,62 млд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору